SymBiosis Capital Management

Venture Capital Bentonville, United States ·Founded 2021

Overview

SymBiosis Capital Management is a venture capital firm dedicated to advancing biotherapeutics innovations for serious and life-threatening diseases. The firm invests in groundbreaking medicines across various disease areas, financing stages, and geographies, with a particular emphasis on programs in or about to enter human trials. SymBiosis currently manages a portfolio of more than 30 investments and has significant, long-term capital commitments to fund future investments. Founded in 2021 and headquartered in Bentonville, Arkansas, SymBiosis is led by Managing Partner Chidozie Ugwumba, who brings extensive experience in partnering with companies developing innovative medicines. The firm's investment strategy is to support private companies with promising biotherapeutic programs, aiming to address unmet medical needs and improve patient outcomes. SymBiosis Capital Management's approach combines deep industry expertise with a commitment to advancing medical breakthroughs. By focusing on early-stage investments in the biotherapeutics sector, the firm seeks to drive the development of transformative therapies that can make a significant impact on global health.

Investment Focus

  • Focus on biotherapeutics innovations
  • Programs in or about to enter human trials
  • Private companies with promising biotherapeutic programs

Reach SymBiosis Capital Management directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about SymBiosis Capital Management

What sectors does SymBiosis Capital Management invest in?

SymBiosis Capital Management invests in Healthcare, Life Sciences and Biotechnology, and is based in Bentonville, United States. SymBiosis Capital Management is listed as a venture capital in the ConnectSafely investor database.

What stage does SymBiosis Capital Management invest at?

SymBiosis Capital Management backs companies at Early Stage, Series A, Series B, Growth, Late Stage and Pre-IPO.

Which regions does SymBiosis Capital Management invest in?

SymBiosis Capital Management invests across United States.

Who are the partners at SymBiosis Capital Management?

Team members listed for SymBiosis Capital Management include Ramona Mullen (Chief of Staff) and Molly Neighbors (Chief Of Staff).

How do I contact SymBiosis Capital Management?

SymBiosis Capital Management's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database